HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,055,080 | +4.0% | 289,400 | -1.8% | 0.01% | +28.6% |
| Q2 2023 | $10,633,436 | -4.6% | 294,800 | +1.0% | 0.01% | -12.5% |
| Q1 2023 | $11,143,842 | -41.1% | 291,800 | -12.3% | 0.01% | -42.9% |
| Q4 2022 | $18,924,940 | +46.3% | 332,600 | +1.7% | 0.01% | +55.6% |
| Q3 2022 | $12,934,000 | -9.4% | 327,100 | +0.8% | 0.01% | -10.0% |
| Q2 2022 | $14,274,000 | +13.2% | 324,400 | +2.6% | 0.01% | +42.9% |
| Q1 2022 | $12,610,000 | +5.4% | 316,200 | +6.2% | 0.01% | 0.0% |
| Q4 2021 | $11,966,000 | -1.6% | 297,600 | -0.4% | 0.01% | -12.5% |
| Q3 2021 | $12,159,000 | -5.5% | 298,900 | +5.5% | 0.01% | 0.0% |
| Q2 2021 | $12,865,000 | +5.2% | 283,300 | -3.4% | 0.01% | 0.0% |
| Q1 2021 | $12,232,000 | -2.7% | 293,400 | -0.3% | 0.01% | -11.1% |
| Q4 2020 | $12,570,000 | +63.1% | 294,300 | +0.4% | 0.01% | +50.0% |
| Q3 2020 | $7,705,000 | -2.0% | 293,200 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $7,861,000 | +70.9% | 293,200 | +14.7% | 0.01% | +40.0% |
| Q1 2020 | $4,600,000 | +3.0% | 255,700 | +1.5% | 0.01% | 0.0% |
| Q4 2019 | $4,468,000 | +16.9% | 252,000 | +2.2% | 0.01% | +25.0% |
| Q3 2019 | $3,823,000 | -8.4% | 246,500 | +1.5% | 0.00% | -20.0% |
| Q2 2019 | $4,173,000 | +9.3% | 242,900 | +2.4% | 0.01% | +25.0% |
| Q1 2019 | $3,817,000 | +13.6% | 237,100 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $3,359,000 | -18.2% | 229,600 | +1.6% | 0.00% | -20.0% |
| Q3 2018 | $4,106,000 | +9.4% | 226,000 | +1.6% | 0.01% | +25.0% |
| Q2 2018 | $3,754,000 | -13.9% | 222,500 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $4,359,000 | -1.1% | 222,500 | +2.3% | 0.01% | 0.0% |
| Q4 2017 | $4,409,000 | +22.9% | 217,600 | +5.4% | 0.01% | +25.0% |
| Q3 2017 | $3,587,000 | +35.5% | 206,500 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $2,647,000 | +13.2% | 206,500 | +14.4% | 0.00% | 0.0% |
| Q1 2017 | $2,339,000 | +31.2% | 180,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,783,000 | -18.2% | 180,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,180,000 | +36.5% | 180,500 | -2.4% | 0.00% | 0.0% |
| Q2 2016 | $1,597,000 | -5.7% | 185,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,693,000 | -34.4% | 185,000 | +24.3% | 0.00% | -50.0% |
| Q4 2015 | $2,579,000 | +29.1% | 148,800 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $1,998,000 | -32.1% | 148,800 | +14.2% | 0.01% | -37.5% |
| Q2 2015 | $2,942,000 | +75.2% | 130,300 | +10.8% | 0.01% | +100.0% |
| Q1 2015 | $1,679,000 | +47.9% | 117,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,135,000 | +8.4% | 117,600 | +2.3% | 0.00% | 0.0% |
| Q3 2014 | $1,047,000 | -7.8% | 115,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,136,000 | -22.2% | 115,000 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $1,461,000 | +20.1% | 115,000 | +41.8% | 0.01% | +20.0% |
| Q4 2013 | $1,216,000 | +35.9% | 81,100 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $895,000 | +54.8% | 81,100 | +11.4% | 0.00% | +33.3% |
| Q2 2013 | $578,000 | – | 72,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |